Skip to Main Content

Paper Details

SARS-CoV-2 S2-targeted vaccination elicits broadly neutralizing antibodies.
Sci Transl Med
51
2022
Author NameAffiliation
Charles SwantonThe Francis Crick Institute
Charles SwantonCancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute
Charles SwantonUniversity College London Cancer Institute
  • 1 - 3

Datasets

Release 1.2